Molecular features in arsenic-induced lung tumors

[1]  S. Lam,et al.  Molecular features in arsenic-induced lung tumors , 2013, Molecular Cancer.

[2]  J. Seymour,et al.  Role of Arsenic Trioxide in Acute Promyelocytic Leukemia , 2013, Current Treatment Options in Oncology.

[3]  Fei Chen,et al.  JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic , 2013, Cell cycle.

[4]  Donna D. Zhang,et al.  Sulforaphane prevents pulmonary damage in response to inhaled arsenic by activating the Nrf2-defense response. , 2012, Toxicology and applied pharmacology.

[5]  Jia Liu,et al.  JNK-dependent Stat3 phosphorylation contributes to Akt activation in response to arsenic exposure. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  V. Papadimitrakopoulou,et al.  Development of PI3K/AKT/mTOR pathway inhibitors and their application in personalized therapy for non-small-cell lung cancer. , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  E. T. Snow,et al.  Modulation of arsenic-induced epidermal growth factor receptor pathway signalling by resveratrol. , 2012, Chemico-biological interactions.

[8]  Liying Wang,et al.  Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. , 2012, Toxicology and applied pharmacology.

[9]  M. Ruchirawat,et al.  Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line , 2012, Environmental Health.

[10]  L. Hudson,et al.  Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  Jianping Zhang,et al.  Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arsenite-induced cell transformation. , 2012, Free radical biology & medicine.

[12]  How-Ran Guo,et al.  Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenic. , 2012, The Science of the total environment.

[13]  Liang Cheng,et al.  Molecular pathology of lung cancer: key to personalized medicine , 2012, Modern Pathology.

[14]  Xu Ma,et al.  MicroRNA‐181b and microRNA‐9 mediate arsenic‐induced angiogenesis via NRP1 , 2012, Journal of cellular physiology.

[15]  P. Toselli,et al.  Microtubules as a Critical Target for Arsenic Toxicity in Lung Cells in Vitro and in Vivo , 2012, International journal of environmental research and public health.

[16]  Yiguo Jiang,et al.  Akt Activation Is Responsible for Enhanced Migratory and Invasive Behavior of Arsenic-Transformed Human Bronchial Epithelial Cells , 2011, Environmental health perspectives.

[17]  F. Gourronc,et al.  Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis , 2012 .

[18]  J. Mi.  Current treatment strategy of acute promyelocytic leukemia , 2011, Frontiers of medicine.

[19]  S. Tsao,et al.  Molecular changes during arsenic‐induced cell transformation , 2011, Journal of cellular physiology.

[20]  W. Lam,et al.  Arsenic Exposure and the Induction of Human Cancers , 2011, Journal of toxicology.

[21]  T. Rossman,et al.  Genetic and epigenetic effects of environmental arsenicals. , 2011, Metallomics : integrated biometal science.

[22]  N. Guo,et al.  Association of Arsenic Exposure with Lung Cancer Incidence Rates in the United States , 2011, PloS one.

[23]  Xianglin Shi,et al.  miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  A. Hartwig,et al.  Arsenicals affect base excision repair by several mechanisms. , 2011, Mutation research.

[25]  Ian M. Wilson,et al.  Genetic Disruption of KEAP1/CUL3 E3 Ubiquitin Ligase Complex Components is a Key Mechanism of NF-KappaB Pathway Activation in Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[26]  S. Flora.  Arsenic-induced oxidative stress and its reversibility. , 2011, Free radical biology & medicine.

[27]  Y. Lou,et al.  Mitochondria are the main target organelle for trivalent monomethylarsonous acid (MMA(III))-induced cytotoxicity. , 2011, Chemical research in toxicology.

[28]  B. Jiang,et al.  Role and Mechanism of Arsenic in Regulating Angiogenesis , 2011, PloS one.

[29]  R. Franco,et al.  Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesis. , 2011, Mutation research.

[30]  G. Goodall,et al.  Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[31]  C. Skibola,et al.  An Emerging Role for Epigenetic Dysregulation in Arsenic Toxicity and Carcinogenesis , 2010, Environmental health perspectives.

[32]  Hong-Fei Xia,et al.  Q 1 MicroRNA-181 b and microRNA-9 Mediate Arsenic-Induced Angiogenesis via NRP 1 , 2011 .

[33]  S. Lam,et al.  Arsenic-related DNA copy-number alterations in lung squamous cell carcinomas , 2010, British Journal of Cancer.

[34]  E. T. Snow,et al.  Age and exposure to arsenic alter base excision repair transcript levels in mice. , 2010, Mutagenesis.

[35]  X. Le,et al.  A review on arsenic concentrations in Canadian drinking water , 2010 .

[36]  P. Tortora,et al.  Polynucleotide phosphorylase and mitochondrial ATP synthase mediate reduction of arsenate to the more toxic arsenite by forming arsenylated analogues of ADP and ATP. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  Arun Kumar,et al.  Arsenic exposure in US public and domestic drinking water supplies: A comparative risk assessment , 2010, Journal of Exposure Science and Environmental Epidemiology.

[38]  T. Rossman,et al.  Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure. , 2010, Toxicology and applied pharmacology.

[39]  A. Puga,et al.  Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. , 2010, Epigenomics.

[40]  B. Diwan,et al.  Arsenic Exposure Transforms Human Epithelial Stem/Progenitor Cells into a Cancer Stem-like Phenotype , 2009, Environmental health perspectives.

[41]  Jessica Zucman-Rossi,et al.  p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos. , 2010, Lung cancer.

[42]  A. Burlingame,et al.  Acetylated H4K16 by MYST1 protects UROtsa cells from arsenic toxicity and is decreased following chronic arsenic exposure. , 2009, Toxicology and Applied Pharmacology.

[43]  David J Lee,et al.  Bladder cancer clusters in Florida: identifying populations at risk. , 2009, The Journal of urology.

[44]  A. Hartwig,et al.  Impact of arsenic on nucleotide excision repair: XPC function, protein level, and gene expression. , 2009, Molecular nutrition & food research.

[45]  A. J. Gandolfi,et al.  Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. , 2009, Toxicology and applied pharmacology.

[46]  A. Andrew,et al.  Arsenic Activates EGFR Pathway Signaling in the Lung , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[47]  Mihee M. Kim,et al.  Induction of cytoplasmic accumulation of p53: a mechanism for low levels of arsenic exposure to predispose cells for malignant transformation. , 2008, Cancer research.

[48]  K. Kitchin,et al.  Evidence against the nuclear in situ binding of arsenicals--oxidative stress theory of arsenic carcinogenesis. , 2008, Toxicology and applied pharmacology.

[49]  Hong Sun,et al.  Arsenite alters global histone H3 methylation. , 2008, Carcinogenesis.

[50]  A. J. Gandolfi,et al.  Epigenetic remodeling during arsenical-induced malignant transformation. , 2008, Carcinogenesis.

[51]  Donna D. Zhang,et al.  Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction. , 2008, Toxicology and applied pharmacology.

[52]  J. Li,et al.  Mechanism of comutagenesis of sodium arsenite withn-methyl-n-nitrosourea , 1989, Biological Trace Element Research.

[53]  A. Zhitkovich,et al.  Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. , 2008, Chemical research in toxicology.

[54]  T. Hei,et al.  Neoplastic Transformation of Human Small Airway Epithelial Cells Induced by Arsenic , 2008, Molecular medicine.

[55]  W. Hung,et al.  Urothelial carcinomas arising in arsenic‐contaminated areas are associated with hypermethylation of the gene promoter of the death‐associated protein kinase , 2007, Histopathology.

[56]  Donna D. Zhang,et al.  Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. , 2007, Toxicology and applied pharmacology.

[57]  P. Hogg,et al.  Arsenical-based cancer drugs. , 2007, Cancer treatment reviews.

[58]  L. Loeb,et al.  Mutation at the Polymerase Active Site of Mouse DNA Polymerase δ Increases Genomic Instability and Accelerates Tumorigenesis , 2007, Molecular and Cellular Biology.

[59]  W. Hung,et al.  Arsenic salts induced autophagic cell death and hypermethylation of DAPK promoter in SV-40 immortalized human uroepithelial cells. , 2007, Toxicology letters.

[60]  T. Rossman,et al.  Further evidence against a direct genotoxic mode of action for arsenic-induced cancer. , 2007, Toxicology and applied pharmacology.

[61]  G. Dianov,et al.  DNA polymerase δ-dependent repair of DNA single strand breaks containing 3′-end proximal lesions , 2007, Nucleic acids research.

[62]  G. Dianov,et al.  Impact of arsenite and its methylated metabolites on PARP-1 activity, PARP-1 gene expression and poly(ADP-ribosyl)ation in cultured human cells. , 2007, DNA repair.

[63]  Barry Halliwell,et al.  Oxidative stress and cancer: have we moved forward? , 2007, The Biochemical journal.

[64]  Karl T Kelsey,et al.  MicroRNA responses to cellular stress. , 2006, Cancer research.

[65]  Weiya Ma,et al.  Arsenite inhibits p53 phosphorylation, DNA binding activity, and p53 target gene p21 expression in mouse epidermal JB6 cells , , 2006, Molecular carcinogenesis.

[66]  K. Hatakeyama,et al.  Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[67]  M. Karagas,et al.  Arsenic Exposure Is Associated with Decreased DNA Repair in Vitro and in Individuals Exposed to Drinking Water Arsenic , 2006, Environmental health perspectives.

[68]  W. Loenen.  S-adenosylmethionine: jack of all trades and master of everything? , 2006, Biochemical Society transactions.

[69]  Sarmishtha Chanda,et al.  DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[70]  Fei Chen,et al.  Nucleolin links to arsenic-induced stabilization of GADD45α mRNA , 2006, Nucleic acids research.

[71]  Donna D. Zhang.  Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway , 2006, Drug metabolism reviews.

[72]  D. Mazumder.  Effect of chronic intake of arsenic-contaminated water on liver. , 2005, Toxicology and applied pharmacology.

[73]  L. Chin,et al.  High-resolution genomic profiles of human lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[74]  M. Mead,et al.  Arsenic: In Search of an Antidote to a Global Poison , 2005, Environmental health perspectives.

[75]  T. Rossman,et al.  Evidence that arsenite acts as a cocarcinogen in skin cancer. , 2004, Toxicology and applied pharmacology.

[76]  S. Leonard,et al.  Cadmium inhibits the electron transfer chain and induces reactive oxygen species. , 2004, Free radical biology & medicine.

[77]  M. David,et al.  Arsenic inhibition of the JAK-STAT pathway , 2004, Oncogene.

[78]  Howard Hu,et al.  Cell type specificity of lung cancer associated with arsenic ingestion. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[79]  F. Caradonna,et al.  Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells. , 2003, Carcinogenesis.

[80]  M. Luster,et al.  Arsenic carcinogenicity: Relevance of c-Src activation , 2002, Molecular and Cellular Biochemistry.

[81]  Xianglin Shi,et al.  Arsenite induces HIF-1α and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells , 2004, Molecular and Cellular Biochemistry.

[82]  J. A. Roberson,et al.  Some drinking-water disinfectants and contaminants, including arsenic. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[83]  Arsenic Book.  Some drinking-water disinfectants and contaminants, including arsenic. Monographs on chloramine, chloral and chloral hydrate, dichloroacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[84]  L. Yih,et al.  Nitric oxide production by arsenite. , 2003, Mutation research.

[85]  T. Rossman.  Mechanism of arsenic carcinogenesis: an integrated approach. , 2003, Mutation research.

[86]  M. Karagas,et al.  FAST TRACK DECREASED DNA REPAIR GENE EXPRESSION AMONG INDIVIDUALS EXPOSED TO ARSENIC IN UNITED STATES DRINKING WATER , 2003 .

[87]  D. DeMarini,et al.  Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: Induction of chromosomal mutations but not gene mutations , 2003, Environmental and molecular mutagenesis.

[88]  S. Minucci,et al.  Activation of Rac1 and the p38 Mitogen-activated Protein Kinase Pathway in Response to Arsenic Trioxide* , 2002, The Journal of Biological Chemistry.

[89]  R. Goldsby,et al.  High incidence of epithelial cancers in mice deficient for DNA polymerase δ proofreading , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[90]  Z. Dong.  The molecular mechanisms of arsenic-induced cell transformation and apoptosis. , 2002, Environmental health perspectives.

[91]  I. Jaspers,et al.  The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. , 2002, Environmental health perspectives.

[92]  D. Nordstrom.  Worldwide Occurrences of Arsenic in Ground Water , 2002, Science.

[93]  P. Smedley,et al.  A review of the source, behaviour and distribution of arsenic in natural waters , 2002 .

[94]  F. Caradonna,et al.  Early induction of genetic instability and apoptosis by arsenic in cultured Chinese hamster cells. , 2002, Mutagenesis.

[95]  R. Goldsby,et al.  High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[96]  Shan Lin,et al.  The cellular metabolism and systemic toxicity of arsenic. , 2001, Toxicology and applied pharmacology.

[97]  T. Rossman,et al.  Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts -- a possible mechanism for arsenite's comutagenicity. , 2001, Mutation research.

[98]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[99]  M. Lieberman,et al.  The MRP2/cMOAT Transporter and Arsenic-Glutathione Complex Formation Are Required for Biliary Excretion of Arsenic* , 2000, The Journal of Biological Chemistry.

[100]  M. Luster,et al.  Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? , 2000, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[101]  A. Smith,et al.  Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. , 2000, Bulletin of the World Health Organization.

[102]  M. Maa,et al.  c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function* , 1999, The Journal of Biological Chemistry.

[103]  S. Parsons,et al.  Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[104]  B. Diwan,et al.  Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[105]  Liang Wang,et al.  Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. , 1997, Mutation research.

[106]  J. Turrens.  Superoxide Production by the Mitochondrial Respiratory Chain , 1997, Bioscience reports.

[107]  A. Hartwig,et al.  Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. , 1997, Carcinogenesis.

[108]  C. Chen,et al.  Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. , 1996, Atherosclerosis.

[109]  M. Gonsebatt,et al.  Aneugenic effect of sodium arsenite on human lymphocytes in vitro: an individual susceptibility effect detected. , 1995, Mutation research.

[110]  A. Smith,et al.  Vascular effects of chronic arsenic exposure: a review. , 1994, Epidemiologic reviews.

[111]  A. Natarajan,et al.  Genotoxic effects of sodium arsenite on human cells. , 1992, Mutation research.

[112]  A. Smith,et al.  Cancer risks from arsenic in drinking water. , 1992, Environmental health perspectives.

[113]  J. Wiencke,et al.  Specificity of arsenite in potentiating cytogenetic damage induced by the DNA crosslinking agent diepoxybutane , 1992, Environmental and molecular mutagenesis.

[114]  T. Cebula,et al.  DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. , 1991, Science.

[115]  B. Freeman,et al.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. , 1991, The Journal of biological chemistry.

[116]  S. Tannenbaum,et al.  Endogenous incorporation of nitric oxide from L-arginine into N-nitrosomorpholine stimulated by Escherichia coli lipopolysaccharide in the rat. , 1991, Carcinogenesis.

[117]  Y. Kurashima,et al.  Tobacco smoking, chewing, and snuff dipping: factors contributing to the endogenous formation of N-nitroso compounds. , 1991, Critical reviews in toxicology.

[118]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[119]  K. Reimer,et al.  Arsenic speciation in the environment , 1989 .

[120]  J. Barrett,et al.  Multiple mechanisms for the carcinogenic effects of asbestos and other mineral fibers. , 1989, Environmental health perspectives.

[121]  K. Jan,et al.  Sodium arsenite enhances the cytotoxicity, clastogenicity, and 6-thioguanine-resistant mutagenicity of ultraviolet light in Chinese hamster ovary cells. , 1985, Mutation research.

[122]  S. Charbonneau,et al.  Human retention studies with 74As. , 1980, Toxicology and applied pharmacology.

[123]  C. W. Greene,et al.  THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY. , 1917, Science.